ArticleNucleic acids research2018

Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.

Sang-Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.